Literature DB >> 10618025

Comparison of bifrontal and bitemporal ECT for major depression.

S H Bailine1, A Rifkin, E Kayne, J A Selzer, J Vital-Herne, M Blieka, S Pollack.   

Abstract

OBJECTIVE: The authors compared the clinical and cognitive effects of bifrontal electrode placement with standard bitemporal electrode placement in the treatment of patients with major depression.
METHOD: Forty-eight patients with unipolar or bipolar depression were treated with a course of bifrontal or bitemporal ECT. The Hamilton Rating Scale for Depression and the standardized Mini-Mental State were administered at baseline and repeated during the course of treatment.
RESULTS: Forty-seven of the 48 patients who completed the course of treatment met remission criteria by the 12th treatment. There were no differences between the patients given bifrontal ECT and those given bitemporal ECT in the number of treatments required to reach remission criteria. The standardized Mini-Mental State scores of the patients given bitemporal ECT worsened more after treatment than did those of the patients given bifrontal ECT.
CONCLUSIONS: Bifrontal electrode placement was as efficacious as bitemporal placement and resulted in less cognitive impairment. A study of the two placements with more cognitive measures is indicated.

Entities:  

Mesh:

Year:  2000        PMID: 10618025     DOI: 10.1176/ajp.157.1.121

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  16 in total

Review 1.  Brain stimulation in psychiatry and its effects on cognition.

Authors:  Kate E Hoy; Paul B Fitzgerald
Journal:  Nat Rev Neurol       Date:  2010-04-06       Impact factor: 42.937

2.  Rational electroconvulsive therapy electrode placement.

Authors:  Conrad M Swartz; Alexander I Nelson
Journal:  Psychiatry (Edgmont)       Date:  2005-07

Review 3.  [Adverse cognitive effects and ECT].

Authors:  Michael Prapotnik; Roger Pycha; Csaba Nemes; Peter König; Armand Hausmann; Andreas Conca
Journal:  Wien Med Wochenschr       Date:  2006-04

4.  Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial.

Authors:  Charles H Kellner; Rebecca Knapp; Mustafa M Husain; Keith Rasmussen; Shirlene Sampson; Munro Cullum; Shawn M McClintock; Kristen G Tobias; Celena Martino; Martina Mueller; Samuel H Bailine; Max Fink; Georgios Petrides
Journal:  Br J Psychiatry       Date:  2010-03       Impact factor: 9.319

Review 5.  Electroconvulsive therapy stimulus parameters: rethinking dosage.

Authors:  Angel V Peterchev; Moacyr A Rosa; Zhi-De Deng; Joan Prudic; Sarah H Lisanby
Journal:  J ECT       Date:  2010-09       Impact factor: 3.635

6.  Controlling stimulation strength and focality in electroconvulsive therapy via current amplitude and electrode size and spacing: comparison with magnetic seizure therapy.

Authors:  Zhi-De Deng; Sarah H Lisanby; Angel V Peterchev
Journal:  J ECT       Date:  2013-12       Impact factor: 3.635

Review 7.  [Electroconvulsive therapy as maintenance therapy and for prevention of recurrence in psychiatric disorders and Parkinson disease].

Authors:  Matthäus Willeit; Nicole Praschak-Rieder; Siegfried Kasper
Journal:  Wien Klin Wochenschr       Date:  2003-05-15       Impact factor: 1.704

8.  Bifrontal ECT for drug-induced psychosis in Parkinson's disease.

Authors:  K Muralidharan; R Thimmaiah; V Chakraborty; S Jain
Journal:  Indian J Psychiatry       Date:  2011-04       Impact factor: 1.759

Review 9.  Noninvasive neuromodulation of the prefrontal cortex in mental health disorders.

Authors:  William T Regenold; Zhi-De Deng; Sarah H Lisanby
Journal:  Neuropsychopharmacology       Date:  2021-07-16       Impact factor: 7.853

10.  Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review.

Authors:  Yuki Tokutsu; Wakako Umene-Nakano; Takahiro Shinkai; Reiji Yoshimura; Tatsuya Okamoto; Asuka Katsuki; Hikaru Hori; Atsuko Ikenouchi-Sugita; Kenji Hayashi; Kiyokazu Atake; Jun Nakamura
Journal:  Clin Psychopharmacol Neurosci       Date:  2013-04-24       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.